VAERS reports by lot

Pfizer Pneumococcal lot GR3620: VAERS reports

31 VAERS reports list lot GR3620 as a Pfizer Pneumococcal vaccine, received between 2023-04-23 and 2024-09-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
6%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5038%
General / Systemic (non-local)1814%
Musculoskeletal1713%
Allergic / Anaphylactic1411%
Dermatological (non-injection-site)1411%
Neurological97%
Cardiac / Cardiovascular43%
Respiratory32%
Gastrointestinal32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida10
Texas5
North Carolina3
California2
Colorado2
Puerto Rico1
Pennsylvania1
Virginia1
Kentucky1
New York1
Iowa1
New Jersey1

Reports by month received

2023-041
2023-056
2023-066
2023-075
2023-083
2023-092
2023-102
2023-113
2024-061
2024-071
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.